Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Caliper settles litigation.


Hopkinton, MA and San Diego, CA 2/26/08 -- Caliper caliper

Instrument that consists of two adjustable legs or jaws for measuring the dimensions of material parts. Spring calipers have an adjusting screw and nut; firm-joint calipers use friction at the joint to hold the legs unmoving.
 Life Sciences has entered into a settlement agreement with AntiCancer, resolving the patent infringement suit that AntiCancer brought against Xenogen in 2005. Caliper acquired Xenogen in 2006 (see IBO Ibo: see Igbo.  2/15/06). Under the settlement, Caliper acquired the right to sublicense AntiCancer's fluorescent protein optical imaging patents, and AntiCancer acquired the right to sublicense Caliper's optical imaging patents in the field of fluorescent protein imaging to a specified annual number of third parties. Each company also received royal free licenses from the other for internal and contract research operations. Further details were not disclosed. The companies also expect to enter into an OEM (Original Equipment Manufacturer) The rebranding of equipment and selling it. The term initially referred to the company that made the products (the "original" manufacturer), but eventually became widely used to refer to the organization that buys the products and  distribution agreement under which Caliper will market and sell certain AntiCancer mouse and cell lines. "In addition to our unique position in bioluminescent bi·o·lu·mi·nes·cence  
n.
Emission of visible light by living organisms such as the firefly and various fish, fungi, and bacteria.



bi
 and fluorescent conjugate conjugate /con·ju·gate/ (kon´jdbobr-gat)
1. paired, or equally coupled; working in unison.

2. a conjugate diameter of the pelvic inlet; used alone usually to denote the true conjugate diameter; see
 imaging, the cross licensing arrangement enables Caliper to provide our existing and prospective license customers with a broader suite of Intellectual property rights for optical imaging with fluorescent proteins," stated Caliper President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  Kevin Hrusovsky. "This should greatly enhance the clarity and breadth of protection associated with these patents."

The settlement appears to be mutually beneficial and will help further development of the in vivo imaging field. AntiCancer provides the MetaMouse and AngioMouse mouse models of cancer, which are used with its OncoBrite .fluorescent proteins.
COPYRIGHT 2008 Strategic Directions International Inc. (SDI)
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2008 Gale, Cengage Learning. All rights reserved.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Executive Briefing: News & Views for Executives
Publication:Instrument Business Outlook
Date:Mar 15, 2008
Words:225
Previous Article:Merck acquires HPLC column company.
Next Article:The life science sales index: a robust fourth quarter.
Topics:



Related Articles
Molecular Devices and Caliper reach settlement.
Business briefs.
Business briefs.
Invitrogen and Clontech settle patent suit.
From the benchtop to the courtroom.
Applied Biosystems and Agilent settle patent suits.
Business briefs.
Business briefs.
BUSINESS BRIEFS.
Invitrogen and Agilent settle patent suits.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles